CNBC’s morning market update shows Dow futures holding steady near +105 points, supported by recovering crude oil prices and signs of cooling economic pressures. Analysts expect momentum to align with rising earnings forecasts in the manufacturing sector. Shares of British pharmaceutical maker GSK ( GSK ) are higher in premarket trading after the company announced it is replacing its chief executive officer. Current CEO Emma Walmsley, who has led the company for nine years, will step down for the position on Jan. 1 and be replaced by the company's chief commercial officer, Luke Miels. The company last year agreed to pay up to $2.2 billion to resolve thousands of lawsuits over allegations that its Zantac heartburn medication caused cancer. U.S.-traded shares of GSK were up about 3% ahead of the bell. Coming into today's session, the stock had gained 18% so far in 2025. Tuesday's moves added to the major U.S. stock indexes' solid monthly gains for September. The S&P 500, which has averaged a 4.2% drop for the month over the last five years, increased more than 3% this month, and the Dow gained nearly 2%. The Nasdaq outperformed with a 5.6% gain in September. CNBC reports Dow futures are +99 points in pre-market, traders eyeing Fed remarks as potential market catalysts later today. Futures and S&P correlation shows consistent bullish bias in the near term.